This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Tyson Foods' Q3 Earnings Beat, Sales Rise on Growth in Most Segments
by Zacks Equity Research
TSN tops third-quarter fiscal 2025 forecasts as pricing strength and protein demand lift sales and earnings despite soft volumes.
Down 8.0% in 4 Weeks, Here's Why You Should You Buy the Dip in Ingredion (INGR)
by Zacks Equity Research
Ingredion (INGR) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Energizer Q3 Earnings & Sales Beat Estimates, Organic Sales Up Y/Y
by Zacks Equity Research
ENR tops Q3 estimates with strong margin gains, boosted by Project Momentum, production credits and higher EPS guidance.
Ingredion (INGR) Tops Q2 Earnings Estimates
by Zacks Equity Research
Ingredion (INGR) delivered earnings and revenue surprises of +3.24% and -3.68%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Kraft Heinz Q2 Earnings Beat Estimates, Organic Sales Down 2% Y/Y
by Zacks Equity Research
KHC tops Q2 estimates despite declines in earnings and organic sales, as pricing gains fail to offset weak volumes.
The Zacks Analyst Blog Highlights Entergy, Fortis, Northwest Natural and Ingredion
by Zacks Equity Research
Entergy, Fortis, NW Natural, and Ingredion stand out as low-beta, high-yield picks amid Fed rate uncertainty and tariff risks.
4 Low-Beta Defensive Stocks to Buy on Over Rate Cut Uncertainty
by Ritujay Ghosh
Amid Fed uncertainty and high inflation, low-beta stocks like ETR, FTS, NWN and INGR offer stable growth and solid yields.
Freshpet (FRPT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Freshpet (FRPT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Ingredion (INGR) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Ingredion (INGR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
INGR vs. DANOY: Which Stock Is the Better Value Option?
by Zacks Equity Research
INGR vs. DANOY: Which Stock Is the Better Value Option?
Are Investors Undervaluing Ingredion (INGR) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Bet on These 4 Stocks With Exciting Interest Coverage Ratios
by Sumit Singh
DIS, URBN, INGR and HBM stand out for their strong interest coverage ratios and solid earnings growth potential.
Buy These 5 Low-Leverage Stocks Amid Impressive Retail Sales Data
by Aparajita Dutta
With retail sales rebounding and Wall Street gaining, low-leverage stocks like NVS, RMD, WAB, ESLT and INGR offer scope for upside.
Are Investors Undervaluing BRF (BRFS) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Top Ag Tech & Food Innovation Stocks to Strengthen Your Portfolio
by Ansuiya Mohta
BYND, HRL and TSN are transforming food with AgTech, from lab-grown meat to smart farming and plant-based proteins.
INGR vs. CELH: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
INGR vs. CELH: Which Stock Is the Better Value Option?
Is Ingredion (INGR) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
5 Low-Beta Defensive Stocks to Buy Amid Sinking Consumer Confidence
by Ritujay Ghosh
As consumer confidence dips, low-beta defensive picks such as MO, INGR and ATO offer growth potential and steady yields.
Bear of the Day: Flowers Foods (FLO)
by David Bartosiak
Baked goods are delicious but profits should be the frosting on the cake.
5 Consumer Staples Stocks to Buy as Fed Keeps Interest Rates Unchanged
by Ritujay Ghosh
As Fed holds rates steady amid global tensions, PM, KO, and other low-beta consumer staples shine as safer bets.
INGR or DANOY: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
INGR vs. DANOY: Which Stock Is the Better Value Option?
Zacks.com featured highlights include Intuit, Fox, Qifu Technology, UGI and Ingredion
by Zacks Equity Research
INTU, FOX, QFIN, UGI, and INGR offer rising dividends, solid growth and stability as markets hover near record highs.
All You Need to Know About Ingredion (INGR) Rating Upgrade to Buy
by Zacks Equity Research
Ingredion (INGR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
5 Solid Dividend Stocks With Rising Payouts for Safe Income
by Sweta Killa
INTU, FOX, QFIN, UGI and INGR stand out given their rising dividends, strong earnings growth and resilient fundamentals.
Should Value Investors Buy Ingredion (INGR) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.